Xavier Heiligenstein

Xavier Heiligenstein is a prominent figure in the biotechnology field, currently serving as the Chief Scientific Officer and founder of CryoCapCell since January 2012, where supervision of biotechnology development and expansion of the company's portfolio, including the CryoCapsule technology for microscopy studies, is a primary focus. Previously, experience includes a post-doctorate at Institut Curie from March 2012 to December 2018, concentrating on developing a groundbreaking correlative light to electron microscopy methodology. Additional academic accomplishments consist of completing a PhD in Cell Biology and Biophysics at Heidelberg University between 2007 and 2011, alongside diverse research roles during Master's and undergraduate studies that sharpened expertise in cell biology and microscopy techniques.